Read-Gene
Innovative genetics
READ-GENE S.A. is an innovative technology company whose goal is to commercialize methods of detecting, preventing and treating various types of malignant tumors.
READ-GENE S.A. is an innovative technology company whose goal is to commercialize methods of detecting, preventing and treating various types of malignant tumors.
READ-GENE S.A. is an innovative technology company whose goal is to commercialize methods of detecting, preventing and treating various types of malignant tumors.
Medical consultations and diagnostic tests are conducted by Innowacyjna Medycyna sp. z o.o. in cooperation with READ-GENE S.A.
Our offer includes, among others: innovative DNA tests allowing for accurate prevention and faster initiation of treatment. The tests usually check whether a given person has genetic tendencies or predispositions to develop, among others: cancer diseases.
Read-Gene SA is composed of recognized and accomplished scientists who work on a daily basis at the International Hereditary Cancer Center (IHCC) at the Pomeranian Medical University in Szczecin, under the leadership of Prof. Jan Lubiński.
Get acquainted with the latest news from our institution's life.
Contact us and we will dispel all your doubts!